KALV

NASDAQStock

KalVista Pharmaceuticals, Inc.

$16.88-0.51 (-2.91%)

52-Week Range

$10.32

$18.44

Key Stats

Market Cap

853.0M

P/E Ratio

—

Dividend Yield

—

Beta

-0.29

Volume

683.6K

Avg Volume

922.1K

Performance

+14.95%

+2.84%

+27.61%

YTD

+12.42%

+37.94%

+133.29%

-47.35%

Price Chart

ETF Exposure

KALV is held by 81 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
EAOR	iShares ESG Aware 60/40 Balanced Allocation ETF	0.00%	40	$729	$29.8M	0.32%
ITOT	iShares Core S&P Total U.S. Stock Market ETF	0.00%	51,902	$947K	$80.22B	0.03%
IWV	iShares Russell 3000 ETF	0.00%	6,526	$119K	$17.30B	0.20%
SCHB	Schwab U.S. Broad Market ETF	0.00%	23,406	$420K	$37.50B	0.03%
USFM.L	UBS MSCI USA Select Factor Mix UCITS ETF USD dis	0.00%	94	$2K	$134.4M	0.25%
VTHR	Vanguard Russell 3000 ETF	0.00%	3,117	$49K	$5.50B	0.06%
VTI	Vanguard Total Stock Market ETF	0.00%	1,349,851	$21.1M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	7,099	$150K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	612	$13K	$1.29B	0.17%
XEQT.TO	iShares Core Equity ETF Portfolio	0.00%	51,902	$74K	$14.63B	0.20%
XUU.TO	iShares Core S&P U.S. Total Market Index ETF	0.00%	51,902	$23K	$3.91B	0.07%
ZPRV.DE	State Street SPDR MSCI USA Small Cap Value Weighted UCITS ETF	0.00%	800	$9K	$757.5M	0.30%
IMID.L	State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)	0.00%	1,000	$15K	$5.16B	0.17%
ITDB	iShares LifePath Target Date 2030 ETF	0.00%	3	$58	$60.6M	0.09%
ITDC	iShares LifePath Target Date 2035 ETF	0.00%	11	$193	$80.3M	0.10%
ITDD	iShares LifePath Target Date 2040 ETF	0.00%	18	$328	$80.4M	0.11%
ITDE	iShares LifePath Target Date 2045 ETF	0.00%	21	$378	$63.0M	0.11%
ITDF	iShares LifePath Target Date 2050 ETF	0.00%	25	$448	$57.9M	0.11%
ITDG	iShares LifePath Target Date 2055 ETF	0.00%	20	$372	$42.1M	0.12%
ITDH	iShares LifePath Target Date 2060 ETF	0.00%	14	$246	$28.3M	0.12%
ITDI	iShares LifePath Target Date 2065 ETF	0.00%	10	$186	$21.0M	0.12%
ITDJ	iShares LifePath Target Date 2070 ETF	0.00%	5	$82	$9.3M	0.12%
LSLT	Pacer Salt Low truBeta US Market ETF	0.00%	853	$12K	$6.8M	0.60%
SLT	Pacer Salt High truBeta US Market ETF	0.00%	853	$12K	$6.3M	0.60%
SPYI.DE	State Street SPDR MSCI All Country World Investable Market UCITS ETF (Acc)	0.00%	1,000	$13K	$4.48B	0.17%
TRPL	Pacer Metaurus US Large Cap Dividend Multiplier 300 ETF	0.00%	853	$12K	$1.0M	0.79%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	66	$1K	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	2,371	$50K	$12.17B	0.24%
VETS	Pacer Military Times Best Employers ETF	0.00%	853	$12K	$1.9M	0.60%
VIRS	Pacer BioThreat Strategy ETF	0.00%	853	$12K	$3.7M	0.70%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	11	$242	$337.7M	0.32%

PreviousPage 2 of 2

About KALV ETF Exposure

KalVista Pharmaceuticals, Inc. (KALV) is held by 81 exchange-traded funds, making it one of the stocks with significant ETF exposure. With a market capitalization of 853.0M, KALV is a widely held institutional stock. The stock currently trades at $16.88. Investors can gain exposure to KALV through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold KALV, sorted by portfolio weight.